BACKGROUND: The World Trade Center (WTC) collapse produced a massive exposure to respirable particulates in New York City Fire Department (FDNY) rescue workers. This group had spirometry examinations pre-September 11, 2001, and post-September 11, 2001, demonstrating declines in lung function with parallel declines in FEV(1) and FVC. To date, the underlying pathophysiologic cause for this has been open to question. METHODS: Of 13,234 participants in the FDNY-WTC Monitoring Program, 1,720 (13%) were referred for pulmonary subspecialty evaluation at a single institution. Evaluation included 919 full pulmonary function tests, 1,219 methacholine challenge tests, and 982 high-resolution chest CT scans. RESULTS: At pulmonary evaluation (median 34 months post-September 11, 2001), median values were FEV(1) 93% predicted (interquartile range [IQR], 83%-101%), FVC 98% predicted (IQR, 89%-106%), and FEV(1)/FVC 0.78 (IQR, 0.72-0.82). The residual volume (RV) was 123% predicted (IQR, 106%-147%) with nearly all participants having normal total lung capacity, functional residual capacity, and diffusing capacity of carbon monoxide. Also, 1,051/1,720 (59%) had obstructive airways disease based on at least one of the following: FEV(1)/FVC, bronchodilator responsiveness, hyperreactivity, or elevated RV. After adjusting for age, gender, race, height and weight, and tobacco use, the decline in FEV(1) post-September 11, 2001, was significantly correlated with increased RV percent predicted (P < .0001), increased bronchodilator responsiveness (P < .0001), and increased hyperreactivity (P = .0056). CT scans demonstrated bronchial wall thickening that was significantly associated with the decline in FEV(1) post-September 11, 2001 (P = .024), increases in hyperreactivity (P < .0001), and increases in RV (P < .0001). Few had evidence for interstitial disease. CONCLUSIONS: Airways obstruction was the predominant physiologic finding underlying the reduction in lung function post-September 11, 2001, in FDNY WTC rescue workers presenting for pulmonary evaluation.
BACKGROUND: The World Trade Center (WTC) collapse produced a massive exposure to respirable particulates in New York City Fire Department (FDNY) rescue workers. This group had spirometry examinations pre-September 11, 2001, and post-September 11, 2001, demonstrating declines in lung function with parallel declines in FEV(1) and FVC. To date, the underlying pathophysiologic cause for this has been open to question. METHODS: Of 13,234 participants in the FDNY-WTC Monitoring Program, 1,720 (13%) were referred for pulmonary subspecialty evaluation at a single institution. Evaluation included 919 full pulmonary function tests, 1,219 methacholine challenge tests, and 982 high-resolution chest CT scans. RESULTS: At pulmonary evaluation (median 34 months post-September 11, 2001), median values were FEV(1) 93% predicted (interquartile range [IQR], 83%-101%), FVC 98% predicted (IQR, 89%-106%), and FEV(1)/FVC 0.78 (IQR, 0.72-0.82). The residual volume (RV) was 123% predicted (IQR, 106%-147%) with nearly all participants having normal total lung capacity, functional residual capacity, and diffusing capacity of carbon monoxide. Also, 1,051/1,720 (59%) had obstructive airways disease based on at least one of the following: FEV(1)/FVC, bronchodilator responsiveness, hyperreactivity, or elevated RV. After adjusting for age, gender, race, height and weight, and tobacco use, the decline in FEV(1) post-September 11, 2001, was significantly correlated with increased RV percent predicted (P < .0001), increased bronchodilator responsiveness (P < .0001), and increased hyperreactivity (P = .0056). CT scans demonstrated bronchial wall thickening that was significantly associated with the decline in FEV(1) post-September 11, 2001 (P = .024), increases in hyperreactivity (P < .0001), and increases in RV (P < .0001). Few had evidence for interstitial disease. CONCLUSIONS: Airways obstruction was the predominant physiologic finding underlying the reduction in lung function post-September 11, 2001, in FDNY WTC rescue workers presenting for pulmonary evaluation.
Authors: Gabriel Izbicki; Robert Chavko; Gisela I Banauch; Michael D Weiden; Kenneth I Berger; Thomas K Aldrich; Charles Hall; Kerry J Kelly; David J Prezant Journal: Chest Date: 2007-03-30 Impact factor: 9.410
Authors: Gwen S Skloot; Clyde B Schechter; Robin Herbert; Jacqueline M Moline; Stephen M Levin; Laura E Crowley; Benjamin J Luft; Iris G Udasin; Paul L Enright Journal: Chest Date: 2009-01-13 Impact factor: 9.410
Authors: D W Dockery; C A Pope; X Xu; J D Spengler; J H Ware; M E Fay; B G Ferris; F E Speizer Journal: N Engl J Med Date: 1993-12-09 Impact factor: 91.245
Authors: Anthony M Szema; Meera Khedkar; Patrick F Maloney; Patricia A Takach; Michael S Nickels; Harshit Patel; Francesmary Modugno; Alan Y Tso; Deborah H Lin Journal: J Allergy Clin Immunol Date: 2004-03 Impact factor: 10.793
Authors: Robin Herbert; Jacqueline Moline; Gwen Skloot; Kristina Metzger; Sherry Baron; Benjamin Luft; Steven Markowitz; Iris Udasin; Denise Harrison; Diane Stein; Andrew Todd; Paul Enright; Jeanne Mager Stellman; Philip J Landrigan; Stephen M Levin Journal: Environ Health Perspect Date: 2006-12 Impact factor: 9.031
Authors: Carey B Maslow; Stephen M Friedman; Parul S Pillai; Joan Reibman; Kenneth I Berger; Roberta Goldring; Steven D Stellman; Mark Farfel Journal: Am J Public Health Date: 2012-04-19 Impact factor: 9.308
Authors: William N Rom; Joan Reibman; Linda Rogers; Michael D Weiden; Beno Oppenheimer; Kenneth Berger; Roberta Goldring; Denise Harrison; David Prezant Journal: Proc Am Thorac Soc Date: 2010-05
Authors: Thomas K Aldrich; Madeline Vossbrinck; Rachel Zeig-Owens; Charles B Hall; Theresa M Schwartz; William Moir; Mayris P Webber; Hillel W Cohen; Anna Nolan; Michael D Weiden; Vasilios Christodoulou; Kerry J Kelly; David J Prezant Journal: Chest Date: 2016-01-13 Impact factor: 9.410
Authors: Michael D Weiden; Bushra Naveed; Sophia Kwon; Soo Jung Cho; Ashley L Comfort; David J Prezant; William N Rom; Anna Nolan Journal: Eur Respir J Date: 2012-08-16 Impact factor: 16.671
Authors: Thomas K Aldrich; Jessica Weakley; Sean Dhar; Charles B Hall; Tesha Crosse; Gisela I Banauch; Michael D Weiden; Gabriel Izbicki; Hillel W Cohen; Aanchal Gupta; Camille King; Vasilios Christodoulou; Mayris P Webber; Rachel Zeig-Owens; William Moir; Anna Nolan; Kerry J Kelly; David J Prezant Journal: Chest Date: 2016-07-19 Impact factor: 9.410
Authors: Jun Tsukiji; Soo Jung Cho; Ghislaine C Echevarria; Sophia Kwon; Phillip Joseph; Edward J Schenck; Bushra Naveed; David J Prezant; William N Rom; Ann Marie Schmidt; Michael D Weiden; Anna Nolan Journal: Biomarkers Date: 2014-02-19 Impact factor: 2.658